Reference Source

Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.

70010-111-01 · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · Granules Pharmaceuticals Inc.

What is the package ndc for 70010-111-01 · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · Granules Pharmaceuticals Inc.?

For 70010-111-01 · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · Granules Pharmaceuticals Inc., package ndc is 70010-111-01; generic name is Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet; manufacturer is Granules Pharmaceuticals Inc; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.

"initial_posting_date": "10/12/2022", "package_ndc": "70010-111-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "877-770-3183", "availability": "Unavailable", "related_info": "Estimated recovery: October 2026"

api.fda.gov, retrieved 2026-09-01

Package NDC
70010-111-01 verified
Generic name
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet verified
Manufacturer
Granules Pharmaceuticals Inc. verified
Status
Current verified
Availability now
Unavailable verified
FDA note
Estimated recovery: October 2026 verified
Initial posting date
10/12/2022 verified
Last update date
08/18/2026 verified
Days in shortage
1420 our reading
Reason for shortage
Shortage of an active ingredient verified
Dosage form
Tablet verified
Therapeutic category
Psychiatry verified
Sourceapi.fda.gov
Verified
Review by
DatasetFDA drug shortage duration tracker

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category

"update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01)", "company_name": "Granules Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current"

— all from api.fda.gov, retrieved 2026-09-01

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.